RJA
LLY icon

Ross\Johnson & Associates’s Eli Lilly LLY Stock Holding History

Ross\Johnson & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6K Hold
17
– – 0.28% 31
2025
Q4 		$18.3K Sell
17
-1
-6% -$956 0.34% 29
2025
Q3 		$13.7K Hold
18
– – 0.26% 29
2025
Q2 		$14K Hold
18
– – 0.29% 27
2025
Q1 		$14.9K Buy
18
+1
+6% +$832 0.26% 43
2024
Q4 		$13.1K Buy
+17
New +$14.1K 0.3% 27

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ross\Johnson & Associates's LLY Position: Q1 2026 in Review

Ross\Johnson & Associates held its Eli Lilly (LLY) position steady in Q1 2026 at 17 shares worth $15.6K. The position accounts for 0.28% of the portfolio, ranked #31.

Ross\Johnson & Associates first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $18.3K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ross\Johnson & Associates held 17 shares of Eli Lilly worth $15.6K as of Q1 2026.
  • Ross\Johnson & Associates left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.28% of Ross\Johnson & Associates's portfolio in Q1 2026, its #31 holding.
  • Ross\Johnson & Associates first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Eli Lilly position peaked at $18.3K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.